Case Series of Multisystem Inflammatory Syndrome in Neonates (MIS-N) With a Link to Coagulopathy
- PMID: 38161855
- PMCID: PMC10756854
- DOI: 10.7759/cureus.49681
Case Series of Multisystem Inflammatory Syndrome in Neonates (MIS-N) With a Link to Coagulopathy
Abstract
Introduction Multisystem inflammatory syndrome in neonates (MIS-N) is an emerging clinical entity observed in neonates born to mothers with exposure to the SARS-CoV-2 virus before or during the antenatal period. Methods We report 18 neonates diagnosed with MIS-N from retrospectively collected data. A total of 18 neonates (13 term and five late-preterm; 10 males) admitted to the neonatal intensive care unit (NICU) of a tertiary care medical institute, between June 2021 to November 2022, were diagnosed with MIS-N. Results The median age of presentation of the 18 neonates was 1.5 days of life. All the neonates were positive for SARS-CoV-2 IgG antibodies and had elevated D-dimer levels. Respiratory system involvement was the most common (12 of 18 neonates: 66.67%). Ten out of 18 neonates (55.55%) had coagulopathy. Seven of the ten neonates with coagulopathy had central nervous system (CNS) involvement as seizures and/or intracerebral infarcts/bleeds. Cardiovascular and gastrointestinal system involvement was observed in nine (50%) and seven (38.89%) neonates, respectively. One out of 18 neonates died due to intraventricular and cerebral hemorrhage. The mortality rate was 5.55% (n=1). Ten of 18 neonates with coagulopathy required fresh frozen plasma along with repeated therapeutic doses of injection vitamin K. Eight neonates (44.44%) required human intravenous immunoglobulin (IVIG), and three neonates (16.67%) required steroids and IVIG for recovery along with supportive care. Conclusion Coagulopathy can be one of the salient features of presentation in MIS-N. In the immediate post-pandemic era, it is essential that MIS-N is considered in the differential diagnosis of neonates presenting with intracerebral bleeds/infarcts. IVIG and steroids might play an important role in the treatment of neonates with MIS-N.
Keywords: coagulopathy; covid-19; intracerebral bleeds; intravenous immunoglobulin; steroids.
Copyright © 2023, Siramdas et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures


Similar articles
-
Multisystem inflammatory syndrome in neonates (MIS-N): a systematic review.Eur J Pediatr. 2023 May;182(5):2283-2298. doi: 10.1007/s00431-023-04906-4. Epub 2023 Mar 6. Eur J Pediatr. 2023. PMID: 36877274 Free PMC article.
-
A case series of coagulopathy in preterm or growth-restricted term neonates born to mothers with antenatal SARS-CoV-2 infection: Neonatal post-COVID-19 coagulopathy?J Family Med Prim Care. 2022 Nov;11(11):7483-7490. doi: 10.4103/jfmpc.jfmpc_1284_22. Epub 2022 Dec 16. J Family Med Prim Care. 2022. PMID: 36993065 Free PMC article.
-
An Insight into Multisystem Inflammatory Syndrome in Adults Associated with Recent SARS-COV-2 Infection: A Case Series.J Assoc Physicians India. 2023 Aug;71(8):11-12. doi: 10.59556/japi.71.0314. J Assoc Physicians India. 2023. PMID: 37651238
-
Neonatal Multisystem Inflammatory Syndrome (MIS-N) Associated with Prenatal Maternal SARS-CoV-2: A Case Series.Children (Basel). 2021 Jul 2;8(7):572. doi: 10.3390/children8070572. Children (Basel). 2021. PMID: 34356552 Free PMC article.
-
Multisystemic Inflammatory Syndrome in Neonates: A Systematic Review.Neonatology. 2022;119(4):405-417. doi: 10.1159/000524202. Epub 2022 May 5. Neonatology. 2022. PMID: 35512651 Free PMC article.
Cited by
-
Multisystem Inflammatory Syndrome in Neonates (MIS-N).Indian J Pediatr. 2025 Aug 14. doi: 10.1007/s12098-025-05727-z. Online ahead of print. Indian J Pediatr. 2025. PMID: 40804560 No abstract available.
References
-
- Neonatal bleeding disorders. A practical diagnostic approach. Katsaras GN, Gialamprinou D, Papacharalampous E, et al. J Pediatr Neonat Individual Med. 2022;11:110231.
LinkOut - more resources
Full Text Sources
Miscellaneous